Global Artificial Organ Technology Market (By Product- Artificial Liver, Artificial Pancreas, Artificial Heart, Artificial Kidney, Bionic Limbs and Others. By Technology- Mechanical Bionics and Electronic Bionics) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025
The report covers the analysis and forecast of the artificial organ technology market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).
The study provides a detailed view of the artificial organ technology market, by segmenting it based on by product, by technology, and regional demand. Rapidly aging population across the world makes the artificial organ market more demanding in these days and in the nearby future. Moreover, in recent days scarcity of organ donors is also expected to augment the market growth of artificial organ technology during the projection period of 2017-2025.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by product, by technology in all regions. These include different business strategies adopted by the leading players and their recent developments.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the artificial organ technology market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the artificial organ technology market.
The report provides the size of the artificial organ technology market in 2016 and the forecast for the next nine years up to 2025. The size of the global artificial organ technology market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
Market estimates for this study have been based on revenue being derived through regional pricing trends. The artificial organ technology market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the artificial organ technology market, split into regions. Based on, product, and technology, the individual revenues from all the regions is summed up to achieve the global revenue for artificial organ technology. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of artificial organ technology several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Gambro AB, Biomet Inc., Ekso Bionics, Medtronic Inc., Baxter International Inc., and few to be named.
The global artificial organ technology market has been segmented into:
Global Artificial Organ Technology Market: By Product
The study provides a detailed view of the artificial organ technology market, by segmenting it based on by product, by technology, and regional demand. Rapidly aging population across the world makes the artificial organ market more demanding in these days and in the nearby future. Moreover, in recent days scarcity of organ donors is also expected to augment the market growth of artificial organ technology during the projection period of 2017-2025.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by product, by technology in all regions. These include different business strategies adopted by the leading players and their recent developments.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the artificial organ technology market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the artificial organ technology market.
The report provides the size of the artificial organ technology market in 2016 and the forecast for the next nine years up to 2025. The size of the global artificial organ technology market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.
Market estimates for this study have been based on revenue being derived through regional pricing trends. The artificial organ technology market has been analyzed based on expected demand. Bottom-up approach is done to estimate the global revenue of the artificial organ technology market, split into regions. Based on, product, and technology, the individual revenues from all the regions is summed up to achieve the global revenue for artificial organ technology. Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of artificial organ technology several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Gambro AB, Biomet Inc., Ekso Bionics, Medtronic Inc., Baxter International Inc., and few to be named.
The global artificial organ technology market has been segmented into:
Global Artificial Organ Technology Market: By Product
- Artificial Liver
- Artificial Pancreas
- Artificial Heart
- Artificial Kidney
- Bionic Limbs
- Others
- Prosthetic
- Bionics
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- France
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Rest of Asia Pacific
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
- Latin America
- Brazil
- Rest of Latin America
1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF ARTIFICIAL ORGAN TECHNOLOGY MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET SNAPSHOT
3.2 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 ARTIFICIAL LIVER
5.3 ARTIFICIAL PANCREAS
5.4 ARTIFICIAL HEART
5.5 ARTIFICIAL KIDNEY
5.6 BIONIC LIMBS
5.7 OTHERS
6 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 PROSTHETIC
6.3 BIONICS
7 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY GEOGRAPHY
7.1 NORTH AMERICA
7.1.1 MARKET DYNAMICS
7.1.1.1 DRIVERS
7.1.1.2 RESTRAINS
7.1.1.3 OPPORTUNITY
7.1.2 U.S.
7.1.3 CANADA
7.1.4 MEXICO
7.2 EUROPE
7.2.1 MARKET DYNAMICS
7.2.1.1 DRIVERS
7.2.1.2 RESTRAINS
7.2.1.3 OPPORTUNITY
7.2.2 U.K.
7.2.3 FRANCE
7.2.4 GERMANY
7.2.5 SPAIN
7.2.6 REST OF EUROPE
7.3 ASIA PACIFIC
7.3.1 MARKET DYNAMICS
7.3.1.1 DRIVERS
7.3.1.2 RESTRAINS
7.3.1.3 OPPORTUNITY
7.3.2 INDIA
7.3.3 CHINA
7.3.4 JAPAN
7.3.5 REST OF ASIA PACIFIC
7.4 MIDDLE EAST AND AFRICA
7.4.1 MARKET DYNAMICS
7.4.1.1 DRIVERS
7.4.1.2 RESTRAINS
7.4.1.3 OPPORTUNITY
7.4.2 SOUTH AFRICA
7.4.3 REST OF MIDDLE EAST AND AFRICA
7.5 LATIN AMERICA
7.5.1 MARKET DYNAMICS
7.5.1.1 DRIVERS
7.5.1.2 RESTRAINS
7.5.1.3 OPPORTUNITY
7.5.2 BRAZIL
7.5.3 REST OF LATIN AMERICA
8 COMPETATIVE LANDSCAPE
8.1 OVERVIEW
8.2 NEW PRODUCT LAUNCHES
9 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY COMPANY
9.1 INTRODUCTION
9.2 MEDTRONIC INC.
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS & SERVICES
9.2.3 KEY STRATEGY
9.2.4 RECENT DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.3 BAXTER INTERNATIONAL INC.
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS & SERVICES
9.3.3 KEY STRATEGY
9.3.4 RECENT DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.4 COCHLEAR LTD.
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS & SERVICES
9.4.3 KEY STRATEGY
9.4.4 RECENT DEVELOPMENTS
9.4.5 SWOT ANALYSIS
9.5 THORATEC CORPORATION
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS & SERVICES
9.5.3 KEY STRATEGY
9.5.4 RECENT DEVELOPMENTS
9.5.5 SWOT ANALYSIS
9.6 GAMBRO AB
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 KEY STRATEGY
9.6.4 RECENT DEVELOPMENTS
9.6.5 SWOT ANALYSIS
9.7 EKSO BIONICS
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS & SERVICES
9.7.3 KEY STRATEGY
9.7.4 RECENT DEVELOPMENTS
9.7.5 SWOT ANALYSIS
9.8 BIOMET INC.
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS & SERVICES
9.8.3 KEY STRATEGY
9.8.4 RECENT DEVELOPMENTS
9.8.5 SWOT ANALYSIS
9.9 NANO RETINA INC.
9.9.1 BUSINESS OVERVIEW
9.9.2 PRODUCTS & SERVICES
9.9.3 KEY STRATEGY
9.9.4 RECENT DEVELOPMENTS
9.9.5 SWOT ANALYSIS
9.10 BERLIN HEART GmbH
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCTS & SERVICES
9.10.3 KEY STRATEGY
9.10.4 RECENT DEVELOPMENTS
9.10.5 SWOT ANALYSIS
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF ARTIFICIAL ORGAN TECHNOLOGY MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET SNAPSHOT
3.2 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET REVENUE, 2017– 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 ARTIFICIAL LIVER
5.3 ARTIFICIAL PANCREAS
5.4 ARTIFICIAL HEART
5.5 ARTIFICIAL KIDNEY
5.6 BIONIC LIMBS
5.7 OTHERS
6 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 PROSTHETIC
6.3 BIONICS
7 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY GEOGRAPHY
7.1 NORTH AMERICA
7.1.1 MARKET DYNAMICS
7.1.1.1 DRIVERS
7.1.1.2 RESTRAINS
7.1.1.3 OPPORTUNITY
7.1.2 U.S.
7.1.3 CANADA
7.1.4 MEXICO
7.2 EUROPE
7.2.1 MARKET DYNAMICS
7.2.1.1 DRIVERS
7.2.1.2 RESTRAINS
7.2.1.3 OPPORTUNITY
7.2.2 U.K.
7.2.3 FRANCE
7.2.4 GERMANY
7.2.5 SPAIN
7.2.6 REST OF EUROPE
7.3 ASIA PACIFIC
7.3.1 MARKET DYNAMICS
7.3.1.1 DRIVERS
7.3.1.2 RESTRAINS
7.3.1.3 OPPORTUNITY
7.3.2 INDIA
7.3.3 CHINA
7.3.4 JAPAN
7.3.5 REST OF ASIA PACIFIC
7.4 MIDDLE EAST AND AFRICA
7.4.1 MARKET DYNAMICS
7.4.1.1 DRIVERS
7.4.1.2 RESTRAINS
7.4.1.3 OPPORTUNITY
7.4.2 SOUTH AFRICA
7.4.3 REST OF MIDDLE EAST AND AFRICA
7.5 LATIN AMERICA
7.5.1 MARKET DYNAMICS
7.5.1.1 DRIVERS
7.5.1.2 RESTRAINS
7.5.1.3 OPPORTUNITY
7.5.2 BRAZIL
7.5.3 REST OF LATIN AMERICA
8 COMPETATIVE LANDSCAPE
8.1 OVERVIEW
8.2 NEW PRODUCT LAUNCHES
9 GLOBAL ARTIFICIAL ORGAN TECHNOLOGY MARKET, BY COMPANY
9.1 INTRODUCTION
9.2 MEDTRONIC INC.
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS & SERVICES
9.2.3 KEY STRATEGY
9.2.4 RECENT DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.3 BAXTER INTERNATIONAL INC.
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS & SERVICES
9.3.3 KEY STRATEGY
9.3.4 RECENT DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.4 COCHLEAR LTD.
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS & SERVICES
9.4.3 KEY STRATEGY
9.4.4 RECENT DEVELOPMENTS
9.4.5 SWOT ANALYSIS
9.5 THORATEC CORPORATION
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS & SERVICES
9.5.3 KEY STRATEGY
9.5.4 RECENT DEVELOPMENTS
9.5.5 SWOT ANALYSIS
9.6 GAMBRO AB
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 KEY STRATEGY
9.6.4 RECENT DEVELOPMENTS
9.6.5 SWOT ANALYSIS
9.7 EKSO BIONICS
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS & SERVICES
9.7.3 KEY STRATEGY
9.7.4 RECENT DEVELOPMENTS
9.7.5 SWOT ANALYSIS
9.8 BIOMET INC.
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS & SERVICES
9.8.3 KEY STRATEGY
9.8.4 RECENT DEVELOPMENTS
9.8.5 SWOT ANALYSIS
9.9 NANO RETINA INC.
9.9.1 BUSINESS OVERVIEW
9.9.2 PRODUCTS & SERVICES
9.9.3 KEY STRATEGY
9.9.4 RECENT DEVELOPMENTS
9.9.5 SWOT ANALYSIS
9.10 BERLIN HEART GmbH
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCTS & SERVICES
9.10.3 KEY STRATEGY
9.10.4 RECENT DEVELOPMENTS
9.10.5 SWOT ANALYSIS
